. . . . . . . "[These data suggest that rituximab exerts clinical activity on heavily pre-treated patients with WM.Furthermore, Weide et al. first reported that WM-associated polyneuropathy can be treated effectively with a combination of chemotherapy and the anti-CD20 monoclonal antibody rituximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:35+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .